2009
DOI: 10.1021/jm900713y
|View full text |Cite
|
Sign up to set email alerts
|

Increasing Selectivity of CC Chemokine Receptor 8 Antagonists by Engineering Nondesolvation Related Interactions with the Intended and Off-Target Binding Sites

Abstract: The metabolic stability and selectivity of a series of CCR8 antagonists against binding to the hERG ion channel and cytochrome Cyp2D6 are studied by principal component analysis. It is demonstrated that an efficient way of increasing metabolic stability and selectivity of this series is to decrease compound lipophilicity by engineering nondesolvation related attractive interactions with CCR8, as rationalized by three-dimensional receptor models. Although such polar interactions led to increased compound select… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
18
0

Year Published

2011
2011
2014
2014

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 26 publications
(18 citation statements)
references
References 92 publications
(261 reference statements)
0
18
0
Order By: Relevance
“…Because of the specific expression of CCR8 on hepatic macrophages and its significant functional involvement in the progression of injury and fibrosis, CCR8 may represent an attractive target for the treatment of chronic liver diseases. Interestingly, several small molecular agonistic and antagonistic drugs have been developed for either CCR8 or CCL1 32, 33. Thus, based on our results, CCR8 antagonism by small‐molecule inhibitors may represent a feasible, promising novel antifibrogenic approach in inflammatory liver diseases.…”
Section: Discussionmentioning
confidence: 64%
“…Because of the specific expression of CCR8 on hepatic macrophages and its significant functional involvement in the progression of injury and fibrosis, CCR8 may represent an attractive target for the treatment of chronic liver diseases. Interestingly, several small molecular agonistic and antagonistic drugs have been developed for either CCR8 or CCL1 32, 33. Thus, based on our results, CCR8 antagonism by small‐molecule inhibitors may represent a feasible, promising novel antifibrogenic approach in inflammatory liver diseases.…”
Section: Discussionmentioning
confidence: 64%
“…4 For example, a molecular unit as small as methyl can improve the IC 50 value of a drug candidate 100-fold in a phenomenon called the “magic methyl effect”. 5,6 In light of these merits, “a call for new C–H methylation reactions” was made recently to encourage academic and industrial chemistry research groups to study the topic in detail. 6 …”
mentioning
confidence: 99%
“…4). 22 As a result of these strong non-hydrophobic interactions 23 between ionizable H-bonding partners, many H 4 R ligands (including the high affinity endogenous ligand histamine) can bind the receptor with a high lipophilic efficiency, 24 explaining the relatively low c  log  P values of H 4 R ligand (Fig. 3).…”
mentioning
confidence: 99%